Tesamorelin Dosage: Protocol and Chart
Tesamorelin is a stabilized GHRH analog and one of the few peptides in this category with approved clinical use for a specific condition. This guide collects reported dosing into a reference chart. Figures reflect research and clinical literature and are not dosing advice.
How tesamorelin is dosed
Tesamorelin is given by subcutaneous injection and dosed in milligrams. In its approved clinical context it is used at a standard daily amount. Research protocols reference that figure as their anchor.
| Context | Reported dose | Frequency |
|---|---|---|
| Clinical reference | 2 mg | Once daily, subcutaneous |
| Research protocols | 1 to 2 mg | Once daily, often at night |
Convert a milligram dose into syringe units with the dosage calculator based on your vial size and water volume. Tesamorelin is usually reconstituted fresh and handled with care.
How it compares
Tesamorelin is distinct from shorter GHRH peptides because it is stabilized against rapid breakdown. For how it differs from another popular growth hormone peptide, see tesamorelin vs ipamorelin. To understand the mechanism first, read what does tesamorelin do.
Consistency and sourcing
As always, measure accurately and source tested material. Browse the wider protocol library for related growth hormone peptides and their handling notes.